Focus on long term safety of biosimilars
Mr Kevin Yoon Executive Director, Intron Biotechnology, South Korea
Singapore, Apr 19, 2010: Super bacteria for antibiotics and protein Bio-Drug as a solution’ will become a hot trend in life science space. Development of biosimilars, diagnosis and treatment of infectious organisms such as virus and bacteria and personalized medicine are the major trends in life sciences industry in Asia Pacific. However, in some of the areas like biosimilars and personalized medicine, the issues of long term safety would still need to be addressed adequately.
| 
Comment on this article
